Melinta Therapeutics to Present at Needham & Company’s 17th Annual Healthcare Conference

NEW HAVEN, Conn. , March 14, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today that Dan Wechsler , President and CEO of Melinta, will be presenting at


Leave a Reply

Your email address will not be published.